24 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... known to have HIV ... Preventing First ... HumanPapillomavirus #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing 1st ... Penicilliosis #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Recommendations for Preventing ... Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... parasitemia and preventing ... #Treatment #management
HIV PrEP (Pre-Exposure Prophylaxis) - Truvada 

HIV Pre-Exposure Prophylaxis (PrEP) is available in the form of
HIV PrEP (Pre-Exposure ... - Truvada HIV ... & side effect management ... effective measure of prevention ... Truvada #Monitoring #Management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing Bacterial ... Bacterial #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Pre-Exposure Prevention ... of VZV Primary ... #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Recommendations for Preventing ... Preventing Development ... measure for the prevention ... Castlemans #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... Leishmaniasis #Prevention ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... mucosal #IDSA #Prevention ... #Treatment #management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Campylobacter jejuni - HIV ... bradycardia, urinary retention ... Syndrome #diagnosis #management